Coronavirus Vaccine Landscape in Pakistan: Where Do We Stand?

Authors

  • Maryam Riaz Tarar Department of Pathology, Shalamar Medical & Dental College, Lahore
  • Shehnoor Azhar University of Health Sciences, Lahore

DOI:

https://doi.org/10.48111/2021.02.12

Keywords:

Clinical trial , COVID-19 vaccination, Coronavirus vaccine, CanSino, BIO ZF2001 Vaccine

Abstract

Developing countries like Pakistan have had an opportunity to make the ongoing pandemic count. The country has already been at the forefront of several natural disasters and conflicts in the past decades. In less than one year, the recruitment of over 25000 volunteers nationwide shows the potential and local expertise available to undertake phase III trials for experimental vaccines. It augurs well for the local population to now be able to partake in high-quality multicountry research given the health emergency created by SARS-CoV-2 since March 2020. Academic institutions have paved the way for the biopharmaceutical sector to capitalize on.

Author Biography

  • Shehnoor Azhar, University of Health Sciences, Lahore

    Assistant Professor of Publich Health, Department of Public Health UHS Lahore

References

????? CanSinoBIO. Accessed June 21, 2021. http://www.cansinotech.com/

Volunteers invited to participate in vaccine trials. Accessed June 21, 2021. https://www.thenews.com.pk/print/825048-volunteers-invited-to-participate-in-vaccine-trials

COVID-19 vaccine tracker and landscape. Accessed June 21, 2021. https://www.who.int/publications/m/item/draft-landscape-of-covid-19-candidate-vaccines

Downloads

Published

2021-06-30

Issue

Section

Invited Commentary

How to Cite

Coronavirus Vaccine Landscape in Pakistan: Where Do We Stand?. (2021). Archives of Surgical Research, 2(2), 65-67. https://doi.org/10.48111/2021.02.12